Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Understand the detailed steps in financial planning that can help you create a solid foundation for your financial future. Start planning today!
21,266 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Duquesne Family Office revealed positions in three AI infrastructure semiconductor firms, signaling a thematic bet on...
Trump calls on Congress to codify a permanent 15% ethanol blend in gasoline, a move aimed at easing prices and streng...
Microsoft’s stock has fallen out of step with broader AI enthusiasm as Copilot results lag and cloud growth cools, le...
Poet Technologies faces a pivotal year as AI-driven optical interconnects scale. This report analyzes catalysts, risk...
As AI accelerates, data centers and their support systems become the real backbone of growth. This article breaks dow...
Boards of public homebuilders are treating scale as a fiduciary test, a shift highlighted by Berkshire Hathaway's Tay...
The relationship between OpenAI and Microsoft once looked like a straightforward path to AI profits. Today, smart mon...
Google’s looming compute constraint and a $462 billion backlog set the stage for a broader AI access debate. Investor...
Meta is pursuing a new play-money prediction market, Arena, designed to test engagement and data signals while naviga...
May 2026 hands investors a surprise: a big jump in M2 money supply could rekindle inflation pressures. Markets weigh ...
Paramount’s theater commitments could reshape local economies nationwide by expanding film production and theater act...